Navigation Links
General Patent Corporation Calls New Patent Reform Bill Harmful to Inventors and Entrepreneurs
Date:4/13/2009

General Patent CEO Alexander Poltorak, writing in the syndicated "Washington Watch" column, strongly criticized the proposed Patent Reform Act of 2009 saying that "recycling a piece of failed legislation is not the best way to protect American inventors and spur innovation."

Suffern, N.Y., (PRWEB) - General Patent Corporation chairman and CEO Alexander Poltorak, writing in the popular syndicated "Washington Watch" column circulated throughout the country, strongly criticized the proposed Patent Reform Act of 2009, and said that "recycling a piece of failed legislation is not the best way to protect American inventors and spur innovation."

Calling the proposed new bill "a warmed-over version of a proposed policy package that didn't pass the first time it was introduced in 2007," Dr. Poltorak said "the apportionment of damages and other changes would weaken patents and make it easier for offshore copycats to bring pirated goods into the U.S. This," he continued, "could have serious consequences for American jobs and the country's competitiveness in the global economy."

The proposed changes would transform the U.S. system for granting patents from a "first-to-invent" basis to the European-style "first-to-file" system, which would lead to a "race to the Patent Office" that favors large corporations over small inventors.

"Many critics," Dr. Poltorak said, believe the proposed changes as currently written "will diminish many of the protections offered by the current law and discourage innovation and venture investment, and make it even more difficult to enforce a patent."

Dr. Poltorak's company, General Patent Corporation, has for the past 22 years assisted inventors and entrepreneurs with licensing and enforcement of their patents, and helped them prote
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Vancouver General Hospital is the First Canadian Institution to Implement Copan WASP(R): Walk-Away Specimen Processor
2. Champions Biotechnology, Inc. Establishes UK Subsidiary and Retains General Manager to Expand Its Personalized Oncology Business
3. Microbia, Inc. Names Mike Doyle as Senior Vice President and General Manager, Nutrition Ingredients
4. Extraordinary General Meetings Statement -- XTL Also Announces Board and Management Changes
5. Spiral Biotech to Introduce New Autoplate Spiral Plating System at ASM General Meeting in May
6. XTL Biopharmaceuticals Ltd. Extraordinary General Meetings Postponed Until March 18, 2009
7. New General Manager, Transition to New Raleigh Offices Highlight Datatrials Expansion of North American Operations
8. Cephalon Appoints Sarma P. Duddu as General Manager and Vice President of Drug Delivery Technologies for CIMA LABS
9. Martek, General Mills Collaborate on Microencapsulation Technology for Food Applications
10. Lafayette General Medical Center is the First Hospital in Louisiana to Use Genetic-Based Technology to Test for Respiratory Disease
11. Senetek PLC Announces 2008 Annual General Meeting Voting Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)CORALVILLE, Iowa, Dec. 4 Vivakor, Inc. (OTC Bulletin Board: VIVK) today confirmed that its shareholders of record on December 1, 2009 will receive the dividend of shares of common stock of HealthAmer
(Date:12/3/2009)HOUSTON, Dec. 3 JourneyLite of Houston, LLC announced today that it has updated its facility to offer patients a second surgical option, vertical sleeve gastrectomy , along with the LAP-BAND®
(Date:12/3/2009)PHILADELPHIA, Dec. 3 Shire plc (LSE: SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical company, today announced a voluntary recall of five lots and voluntary market withdrawal of one lot
(Date:12/3/2009)NEW DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D.,Chief Science Officer at Shenzhen Beike Biotechnology Co. Ltd.,( http://www.beikebiotech.com ), spoke at a conference on Hig
Breaking Biology Technology:Vivakor Confirms Record Date of Stock Dividend 2Vivakor Confirms Record Date of Stock Dividend 3JourneyLite of Houston Now Offering Sleeve Gastrectomy 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3
...N.J. and EMERYVILLE, Calif., May 14 Bayer HealthC..., Inc. (Nasdaq: ONXX ) today announced that more...(sorafenib) tablets will be presented at the 2009 ...l meeting. , , "Nexavar has a proven track record... hepatocellular carcinoma (HCC), or liver cancer, ...
..., May 14 ANY LAB TEST NOW(R), the first retail di...ations nationwide, has partnered with Atherotech, ...to provide the VAP(R) Cholesterol Test direct to c...ol Test is an expanded cholesterol profile that id... the first cholesterol test to directly measure LD...
...LE, Md., May 14 Vanda Pharmaceuticals Inc. (Nasda...osters on its newly approved atypical antipsychoti... Psychiatric Association (APA) annual meeting in S... for the acute treatment of schizophrenia in adult...teon at APA. Tasimelteon is an investigational co...
Other Biology Technology:Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 2Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 3Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 4Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 5Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 6VAP(R) Cholesterol Test Now Available at ANY LAB TEST NOW(R) 2VAP(R) Cholesterol Test Now Available at ANY LAB TEST NOW(R) 3Vanda Pharmaceuticals to Present Data on Fanapt(TM) and Tasimelteon at the 162nd American Psychiatric Association Annual Meeting 2Vanda Pharmaceuticals to Present Data on Fanapt(TM) and Tasimelteon at the 162nd American Psychiatric Association Annual Meeting 3Vanda Pharmaceuticals to Present Data on Fanapt(TM) and Tasimelteon at the 162nd American Psychiatric Association Annual Meeting 4
(Date:12/3/2009)WALL, N.J., Dec. 3 BIO-key International, Inc. (OTC Bulletin Board: BKYI), a leader in wireless public safety and finger-based biometric identification solutions, announced that a majority of its sha
(Date:12/3/2009)A coating on windows or solar panels that repels grime and dirt? Expanded battery storage capacities for the next electric car? New Tel Aviv University research, just published in Nature Nanotechnolo
(Date:12/3/2009)Grand Rapids, Mich. (Dec. 3, 2009) Van Andel Research Institute (VARI) researchers have determined precisely how the plant hormone abscisic acid (ABA) works at the molecular level to help plants re
Breaking Biology News(10 mins):BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3A window that washes itself? 2VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3Consumer Reports Health News August 2009 55382 1Consumer Reports Health News August 2009 55382 2Consumer Reports Health News August 2009 55382 3Consumer Reports Health News August 2009 55382 4Trans Ionics Announces New Service Custom Separation Synthesis 28CSS 29 28TM 29 55378 1Trans Ionics Announces New Service Custom Separation Synthesis 28CSS 29 28TM 29 55378 2Hard To Treat Diseases 28HTDS PK 29 IP Rights Pink Sheets Filings 55374 1Hard To Treat Diseases 28HTDS PK 29 IP Rights Pink Sheets Filings 55374 2Hard To Treat Diseases 28HTDS PK 29 IP Rights Pink Sheets Filings 55374 3Hard To Treat Diseases 28HTDS PK 29 IP Rights Pink Sheets Filings 55374 4
...entists have identified one of the genes implicate...mmon cause of blindness in developed countries. , ...et , adds to the growing understanding of the gene...ich the researchers believe should ultimately lead...o-thirds of people aged 80 years or older are affe...
...versity of Iowa researchers and colleagues in Fran...tentially fatal human heart rhythm disorder called...drome," the disease affects approximately one in 6... for 50 percent or more of the permanent pacemaker...wly discovered gene variant is rare, the study pro...
... atomic-resolution view of an enzyme found only in...f Washington (UW) clues about how this enzyme, ess...odiesterase 6 (PDE6), is central to the way light ... signals to the brain. , This particular form of...the retina and has not been well-researched, in co...
Other Biology News:Genetic finding implicates innate immune system in major cause of blindness 2Study provides insight on a common heart rhythm disorder 2Study provides insight on a common heart rhythm disorder 3Atomic-resolution views suggest function of enzyme that regulates light-detecting signals in eye 2
SURE E. coli Strain from Stratagene
21-mer duplex from B-Bridge International
...dy to CRF The antibody blocks specificially with ... Cells and fibres are found in the paraventricular...reated 4% FA perfused tissue. Immunogen: CRF: ...s-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Thr-Lys-Ala-Asp-...
JM101 E. coli Strain from Stratagene
Biology Products: